Hubei Biocause Pharmaceutical Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Wenxia Zhou
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 4yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 5.8yrs |
Recent management updates
CEO
Wenxia Zhou (51 yo)
4yrs
Tenure
CN¥2,015,000
Compensation
Ms. Wenxia Zhou serves as Vice Chairman and Director of Hubei Biocause Pharmaceutical Co., Ltd since June 12, 2020 and its General Manager May 26, 2020.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Vice Chairman & GM | 3.9yrs | CN¥2.02m | no data | |
CFO & Director | 3.9yrs | CN¥590.40k | no data | |
Secretary of the Board & Non-Independent Director | 3.9yrs | CN¥250.00k | no data | |
Chairman of the Board of Directors | 9.2yrs | no data | 10.47% CN¥ 1.2b | |
Chairman of the Supervisory Board | 11.8yrs | no data | no data | |
Independent Director | 5.8yrs | CN¥12.00k | no data | |
Independent Director | 5.8yrs | CN¥12.00k | no data | |
Supervisory Board Member | 6yrs | no data | no data | |
Employee Supervisor | 4.1yrs | no data | no data |
5.8yrs
Average Tenure
53yo
Average Age
Experienced Board: 000627's board of directors are considered experienced (5.8 years average tenure).